F11R and breast cancer: However, Mc Sherry et al. [21], using larger clinical data sets (a 270 patient invasive breast cancer tissue microarray [TMA] and an independent data set of gene expression information from 295 patients with primary breast cancer), showed a positive correlation between JAM-A expression and invasive breast cancer prognosis, which was further confirmed by their another published report using a larger data set [24].